Abstract
The 8 th edition of UICC/AJCC TNM staging for esophageal cancer will start in use since 2018. The nodal staging in this version of TNM system remains unchanged from the 7 th edition that based on the number of lymph nodes (LN) involved, except the limited revision of the regional LN map. In this review, N staging revision was evaluated from its initially simple definition of negative (N0) and positive (N1) LN(s) to the current positive node number based proposal. Meanwhile the disadvantages of current N staging were discussed. The refined nodal staging system in view of the number of metastatic node stations was introduced; as well as the extent and station of metastatic node could better reflect the disease progression and prognosis. The controversy on N staging of esophagogastric junction cancer was also discussed. Other reported N staging associated elements including LN ratio and lymphatic vessel invasion were reviewed and evaluated.
Cite
CITATION STYLE
Wang, W.-P., He, S.-L., Yang, Y.-S., & Chen, L.-Q. (2018). Strategies of nodal staging of the TNM system for esophageal cancer. Annals of Translational Medicine, 6(4), 77–77. https://doi.org/10.21037/atm.2017.12.17
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.